{"id":"NCT00789191","sponsor":"Novo Nordisk A/S","briefTitle":"Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes","officialTitle":"Effect of Detemir and Sitagliptin on Blood Glucose Control in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2009-08","completion":"2009-08","firstPosted":"2008-11-11","resultsPosted":"2010-12-10","lastUpdate":"2017-03-14"},"enrollment":222,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin detemir","otherNames":[]},{"type":"DRUG","name":"sitagliptin","otherNames":[]},{"type":"DRUG","name":"metformin","otherNames":[]},{"type":"DRUG","name":"sulphonylurea","otherNames":[]}],"arms":[{"label":"Comb","type":"EXPERIMENTAL"},{"label":"Sita","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia, Europe and North America. This trial aims for comparison of the effect on the glycemic control in subjects with type 2 diabetes of basal insulin analogue with one oral anti-diabetic drug (OAD) versus oral anti-diabetic drug alone.","primaryOutcome":{"measure":"HbA1c (Glycosylated Haemoglobin A1c)","timeFrame":"Week 26","effectByArm":[{"arm":"Comb","deltaMin":7.08,"sd":0.09},{"arm":"Sita","deltaMin":7.64,"sd":0.09}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0010"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":9},"locations":{"siteCount":51,"countries":["United States","Canada","Finland","France","Hungary","Slovakia","South Korea","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["21205123"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":107},"commonTop":["Nasopharyngitis","Headache","Upper Respiratory Tract Infection","Nausea","Oropharyngeal pain"]}}